2025-05-14 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA) based on the data you provided, formatted as requested:

## NTRA (Natera Inc.) Stock Analysis

**Natera Inc. (NTRA) is a diagnostics company focusing on genetic testing, particularly in reproductive health.**

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return (NTRA):** 130.12%
*   **Cumulative Return (VOO):** 82.18%
*   **Absolute Divergence:** 47.9%
*   **Relative Divergence:** 13.6% (This means the current divergence is in the 13.6th percentile of its historical range.)

**Analysis:** NTRA has significantly outperformed the S&P 500 over the analyzed period.  However, the relative divergence suggests that while positive, the current outperformance isn't exceptionally high compared to its historical divergence range. It's closer to the low end.

**Alpha/Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
| ---------- | ------- | ----- | ------- | ----- | ------ |
| 2015-2017  | -6.0%   | 62.4% | -31.0%  | -0.0  | 1.2   |
| 2016-2018  | 29.0%   | 80.1% | 11.0%   | 0.1   | 1.9   |
| 2017-2019  | 159.0%  | 80.1% | 130.0%  | 1.2   | 4.6   |
| 2018-2020  | 530.0%  | 80.1% | 505.0%  | 0.6   | 13.6  |
| 2019-2021  | 356.0%  | 62.9% | 301.0%  | 0.2   | 12.8  |
| 2020-2022  | -119.0% | 62.9% | -125.0% | 0.3   | 5.5   |
| 2021-2023  | -482.0% | 69.9% | -499.0% | 1.2   | 8.6   |
| 2022-2024  | -75.0%  | 70.5% | -92.0%  | 1.3   | 21.6  |
| 2023-2025  | 79.0%   | 72.8% | 49.0%   | 0.9   | 20.8  |

**Analysis:**

*   **CAGR Volatility:** The Compound Annual Growth Rate (CAGR) shows significant volatility, with periods of extremely high growth followed by substantial declines. This indicates a high-risk, high-reward stock.
*   **High MDD:** The Maximum Drawdown (MDD) is consistently high, highlighting the potential for significant losses.
*   **Varying Alpha:** Alpha fluctuates greatly, indicating periods where NTRA significantly outperformed or underperformed its benchmark.
*   **Beta:** Beta varies, but generally indicates that the stock's volatility is similar to or slightly higher than the market.

### 2. Recent Price Action

*   **Last Price:** 152.28
*   **Previous Close:** 157.29
*   **Change:** -3.19
*   **5-day Moving Average:** 156.838
*   **20-day Moving Average:** 152.8785
*   **60-day Moving Average:** 149.9725

**Analysis:** The stock price has recently decreased, as evidenced by the negative change and the price being below the 5-day moving average, but close to the 20 day average and above the 60 day average. The decline of -3.19 suggests a notable downward move in the last trading session.

### 3. Technical Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.348 (Low Risk)
*   **RSI:** 53.75 (Neutral)
*   **PPO:** 0.0514 (Positive Momentum)
*   **Delta (20-day Relative Divergence):** -2.1 (Short-term Decline)
*   **Expected Return:** 133.9%

**Analysis:**

*   The MRI indicates a low market risk environment for the stock currently.
*   The RSI is neutral, suggesting the stock is neither overbought nor oversold.
*   The PPO indicates positive momentum
*   The decrease in relative divergence suggests that NTRA's recent performance relative to the S&P 500 has weakened.
*   The high expected return suggests significant potential upside over the long term, but should be viewed with caution given the stock's volatile history.

### 4. Recent News & Significant Events

*   **2025-05-11:** Major business developments, regulatory changes, or market events.
*   **2025-05-12:** Analysts are discussing recent performance and outlook.
*   **2025-05-13:** Notable stock volatility.
*   **2025-05-14:** Market experts highlight both risks and opportunities.

**Analysis:** The news suggests recent activity and potential volatility around the stock, potentially influenced by company-specific events and market sentiment.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출      |
| ---------- | ----- | --------- |
| 2025-05-09 | -0.5  | 0.50 B$   |
| 2024-11-12 | -0.26 | 0.44 B$   |
| 2024-08-09 | -0.3  | 0.41 B$   |
| 2024-05-10 | -0.56 | 0.37 B$   |
| 2025-05-09 | -0.56 | 0.37 B$   |

**Analysis:** The company is not currently profitable as indicated by the negative EPS values. Revenue has been generally increasing over the quarters, indicating growth, but profitability remains a challenge.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| ------------ | --------- | ------------- |
| 2025-03-31   | $0.50B    | 63.12%        |
| 2024-12-31   | $0.48B    | 62.94%        |
| 2024-09-30   | $0.44B    | 61.79%        |
| 2024-06-30   | $0.41B    | 58.83%        |
| 2024-03-31   | $0.37B    | 56.72%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
| ------------ | --------- | --------- |
| 2025-03-31   | $1.24B    | -5.40%    |
| 2024-12-31   | $1.20B    | -4.50%    |
| 2024-09-30   | $0.88B    | -3.60%    |
| 2024-06-30   | $0.84B    | -4.48%    |
| 2024-03-31   | $0.79B    | -8.51%    |

**Analysis:**

*   **Revenue Growth:**  Revenues have shown consistent growth over the past several quarters.
*   **High Profit Margins:** Despite not being profitable overall (as seen in the EPS), the company maintains very high profit margins on its revenue. This suggests strong pricing power.
*   **Equity Growth:**  Equity has increased, indicating the company is building its asset base.
*   **Negative ROE:**  Return on Equity (ROE) is negative, confirming that the company is currently not generating profits relative to its equity.  However, the trend is improving.

### 7. Overall Analysis

Natera Inc. (NTRA) presents a mixed picture.

*   **Strengths:** High revenue growth, very high profit margins, significant historical outperformance against the S&P 500, potentially significant long-term upside, and growing equity.
*   **Weaknesses:** Currently unprofitable, high stock price volatility, significant maximum drawdown potential, and recent underperformance relative to the S&P 500.
*   **Considerations:** The company operates in a dynamic industry (genetic testing) and is subject to regulatory and market-driven changes. Recent news and analyst activity suggest potential catalysts for both upside and downside.

**Investment Recommendation:** NTRA appears to be a high-risk, high-reward stock. The high expected return is attractive, but investors should be aware of the potential for significant losses. A potential investment in NTRA would be suitable for investors with a high-risk tolerance and a long-term investment horizon, who are comfortable with volatility and understand the specific risks associated with the genetic testing industry.  It is crucial to stay informed about company-specific news, industry trends, and regulatory developments.

**Disclaimer:** This analysis is based solely on the data provided and does not constitute financial advice. Conduct thorough research and consult with a financial advisor before making any investment decisions.
